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2011a). Finally, the findings of Wong’s
study may have implications for the
establishment of the mammalian
barrier in utero. The hypoxic environ-
ment of the epidermis, which correlates
in time with the period of barrier
acquisition in the mouse during late
embryonic development, could be the
primary trigger for initiating barrier
acquisition. These observations suggest
that the hypoxia-stimulated pathways
may be considered as a therapy for the
skin barrier impairment in prematurity,
by recapitulating the hypoxic epidermal
environment in utero.
The observation that HIFs have a key
role in epidermal barrier formation
emphasizes the significance of hypoxic
responses on the development
and maintenance of the skin’s most
important function––that of protecting
the body’s internal environment from
external stress.
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On the Role of the Endogenous
Opioid System in Regulating Epidermal
Homeostasis
Andrzej T. Slominski1,2
The presence of functional opioid receptors on epidermal keratinocytes, with
attendant regulation of keratinocyte proliferation and differentiation, indicates
their novel role in maintaining epidermal homeostasis. Expression of proenke-
phalin precursors and neuropeptide products in the same compartment opens an
opportunity for studying the role of this endogenous opioid circuitry, with its
regulators, in modulating epidermal barrier function.
Journal of Investigative Dermatology (2015) 135, 333–334. doi:10.1038/jid.2014.458
Expression of functional d-opioid
receptors in the epidermis
In this issue of JID, Dr Bigliardi’s team
presents evidence that d-opioid receptors
(DORs) are expressed in the suprabasal
layers of the epidermis and that they are
phenotypically active (Neumann et al.,
2014). Specifically, ligand activation of
DORs can stimulate the extracellular
signal–regulated kinase 1/2 mitogen-
activated protein kinase pathway with
attendant effects on keratinocyte prolif-
eration and differentiation programs. The
authors conclude that DOR activity in
human keratinocytes can profoundly
affect epidermal morphogenesis and
homeostasis with implications in skin
physiology and pathology.
An endogenous opioid signaling system
in the epidermis
Interestingly, DORs are expressed pre-
dominantly in the suprabasal differen-
tiated layers of the human epidermis,
with expression patterns that are almost
identical to those of proenkephalin
(PENK) and Met- and Leu-enkephalin
antigens (Slominski et al., 2011). Be-
cause enkephalins serve as ligands for
DORs, both findings (Slominski et al.,
2011; Neumann et al., 2014) identify a
novel opioid system composed of
endogenously produced enkephalins
that would act in a para- or autocrine
manner to regulate epidermal homeo-
stasis.
Because the epidermis, serving as a
physical and biological barrier (Feingold
and Elias, 2014), senses and reacts to
environmental factors to regulate epi-
dermal and skin homeostasis (Slominski
and Wortsman, 2000; Slominski et al.,
2012), the local endogenous opioido-
genic system should also be regulated
by environmental factors in order to
have a significant role in the regulation
of local homeostasis. In agreement with
this concept, expression of PENK and
PENK-derived neuropeptides is regula-
ted by TLR4 (LPS) and TLR2
(PAM3CSK4) agonists as well as by
UVB radiation (Slominski et al., 2011),
indicating that production of PENK-
derived neuropeptides can be stimula-
ted by biological and physical insults.
However, it still remains to be
determined whether similar biological
and physical insults regulate DOR
expression in a manner similar to the
regulation of melanocortin receptors,
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which are widely expressed in human
skin (Bohm et al., 2006; Slominski et al.,
2012). In addition, the proposed role of
DORs in wound healing (Neumann
et al., 2014) would require determining
whether physical disruption of the skin
barrier also enhances the expression of
PENK as a part of skin wound healing
processes; this could be similar to the
mechanisms of skin responses to stress
that rely on the action of complex
neuropeptides (Slominski et al., 2000;
McLaughlin and Zagon, 2012;
Slominski et al., 2013).
Potential functions of the cutaneous
opioid system
As indicated by Neumann et al. (2014),
in conjunction with regulated produc-
tion of PENK-derived peptides
(Slominski et al., 2011) and the
complex role of opioids in regulating
cell proliferation and the function of epi-
thelia (McLaughlin and Zagon, 2012),
the local opioid system would include
the opioid growth factor (OGF)—OGF
receptor (OGFr) axis, acting as a
homeostatic regulator of the epidermis
as proposed by McLaughlin and Zagon
(2012).
A local opioid system
regulates epidermal
homeostasis.
Additional functions of local opioid
activity would be secondary to a
well-documented immunomodulatory
role of PENK-derived peptides that
includes stimulation of innate immunity,
which is conserved across many species
(Tasiemski et al., 2000; Metz-Boutigue
et al., 2003). These functions were dis-
cussed previously in the context of
regulating local skin immunity and
antimicrobial activities (Slominski
et al., 2011). The stimulation of the
innate immune activity by opioids
could be crucial in regulating wound
healing and restoration of epidermal
integrity, particularly when the latter is
disrupted by UVB radiation (Slominski
et al., 2011, 2012).
Consistent with the above is de-
regulated expression of PENK anti-
gens in pathological skin, including
psoriasis, inflammatory dermatoses,
and neoplastic processes (Slominski
et al., 2011). The above pattern of
PENK expression nicely complements
the hypothesis that the activity of DOR
is spatially and temporally controlled in
human skin, affecting skin physio-
logy and pathology (Neumann et al.,
2014), with implications in dermato-
pharmacology, as also proposed by
Slominski et al. (2011). McLaughlin
and Zagon (2012), and Slominski et al.
(2012).
Integration of local opioid activity with
the skin neuroendocrine system
It must be noted that skin cells and
cutaneous nerve endings also express
the following: 1) other opioid receptors,
including m- and k-opioid receptors
(McLaughlin and Zagon, 2012;
Slominski et al., 2012; Neumann et al.,
2014); 2) proopiomelanocortin (POMC),
together with a molecular system
regulating its processing toward
b-endorphins that include PC1 and
PC2 convertases; 3) melanocortin
peptides and 4) a CRH signaling
system regulating POMC processing in
a context-dependent manner (Slominski
et al., 2000, 2013). PC1 and PC2
convertases process both PENK and
POMC precursors toward final regula-
tory neuropeptides in a regulated
manner. Thus, the extended local
opioid system (Slominski et al., 2000,
2011; McLaughlin and Zagon, 2012;
Neumann et al., 2014) can be inte-
grated into the function of the broader
skin neuroendocrine system regulating
homeostasis at local and systemic
levels, including sending signals to the
brain (Slominski and Wortsman, 2000;
Slominski et al., 2012).
In this context, the extended opioid
cutaneous system is highly organized,
encoding mediators and receptors
coupled differentially to signal transduc-
tion systems and endowed with stress-
neutralizing activities. This system helps
to maintain skin integrity and to restrict
stress-dependent disruptions of internal
homeostasis. From the evolutionary
point of view, such a system could
develop in the integument, as proposed
for the hypothalamic-pituitary-adrenal
axis (Slominski, 2007), in order to
protect an integrity of the integument.
During evolution, the DOR system has
adapted as an efficient regulator of
central and systemic homeostasis.
Thus, the paper by Neumann et al.
(2014) opens up new areas of
dermatological exploration.
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